Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons

Journal of Physiology

Volumn 587, Issue 2, 2009, Pages 345-361

  Yang, Kechun ^a,b   Hu, Jun ^a   Lucero, Linda ^a   Liu, Qiang ^a   Zheng, Chao ^a   Zhen, Xuechu ^b   Jin, Guozhang ^b   Lukas, Ronald J ^a   Wu, Jie ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CYTISINE; DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; METHYLLYCACONITINE; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR ALPHA 2; NICOTINIC RECEPTOR ALPHA 4; NICOTINIC RECEPTOR ALPHA 5; NICOTINIC RECEPTOR BETA 2; NICOTINIC RECEPTOR BETA 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; KINETICS; NONHUMAN; PATCH CLAMP; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR AFFINITY; REINFORCEMENT; REWARD; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM; WHOLE CELL; ACTION POTENTIAL AMPLITUDE; ACTION POTENTIAL DURATION; ANIMAL TISSUE; CELL FUNCTION; FIRING RATE; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CELL MEMBRANE STEADY POTENTIAL;

ACETYLCHOLINE; ACONITINE; ACTION POTENTIALS; ALKALOIDS; ANIMALS; AZOCINES; BRAIN; CHOLINE; DIHYDRO-BETA-ERYTHROIDINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; KINETICS; MECAMYLAMINE; NEURONS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PATCH-CLAMP TECHNIQUES; PROTEIN SUBUNITS; QUINOLIZINES; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 58349087441     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.162743     Document Type: Article

References (40)

1. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM & Maelicke A (1997). Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280, 1117-1136.
2. Alkondon M & Albuquerque EX (1993). Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265, 1455-1473.
3. Azam L, Chen Y & Leslie FM (2007). Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons. Neuroscience 144, 1347-1360.
4. Azam L, Winzer-Serhan UH, Chen Y & Leslie FM (2002). Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol 444, 260-274.
5. Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP & Bertrand D (1996). Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. J Neurosci 16, 7880-7891.
6. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, Clementi F, Moretti M, Rossi FM, Le Novere N, McIntosh JM, Gardier AM & Changeux JP (2003). Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23, 7820-7829.
7. Charpantier E, Barneoud P, Moser P, Besnard F & Sgard F (1998). Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport 9, 3097-3101.
8. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ & Johnson EC (1997). Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280, 346-356.
9. Corrigall WA, Coen KM & Adamson KL (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653, 278-284.
10. Dani JA & De Biasi M (2001). Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70, 439-446.
11. Dani JA & Heinemann S (1996). Molecular and cellular aspects of nicotine abuse. Neuron 16, 905-908.
12. Dani JA, Ji D & Zhou FM (2001). Synaptic plasticity and nicotine addiction. Neuron 31, 349-352.
13. Di Matteo V, Pierucci M, Di Giovanni G, Benigno A & Esposito E (2007). The neurobiological bases for the pharmacotherapy of nicotine addiction. Curr Pharmacol Des 13, 1269-1284.
14. Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM, Bupp S, Heintz N, McIntosh JM, Bencherif M, Marks MJ & Lester HA (2008). In vivo activation of midbrain dopamine neurons via sensitized, high-affinity α6 nicotinic acetylcholine receptors. Neuron 60, 123-136.
15. Eaton JB, Peng JH, Schroeder KM, George AA, Fryer JD, Krishnan C, Buhlman L, Kuo YP, Steinlein O & Lukas RJ (2003). Characterization of human α4β2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells. Mol Pharmacol 64, 1283-1294.
16. Ishihara K, Alkondon M, Montes JG & Albuquerque EX (1995). Nicotinic responses in acutely dissociated rat hippocampal neurons and the selective blockade of fast-desensitizing nicotinic currents by lead. J Pharmacol Exp Ther 273, 1471-1482.
17. Klink R, de Kerchove d'Exaerde A, Zoli M & Changeux JP (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21, 1452-1463.
18. Le Novere N, Corringer PJ & Changeux JP (2002). The diversity of subunit composition in nAChRs: Evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53, 447-456.
19. Le Novere N, Zoli M & Changeux JP (1996). Neuronal nicotinic receptor α 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8, 2428-2439.
20. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP & Faure P (2006). Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50, 911-921.
21. Mansvelder HD, De Rover M, McGehee DS & Brussaard AB (2003). Cholinergic modulation of dopaminergic reward areas: Upstream and downstream targets of nicotine addiction. Eur J Pharmacol 480, 117-123.
22. Margolis EB, Lock H, Hjelmstad GO & Fields HL (2006). The ventral tegmental area revisited: Is there an electrophysiological marker for dopaminergic neurons? J Physiol 577, 907-924.
23. Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, McIntosh JM, Rossi F, Champtiaux N, Zoli M & Changeux JP (2003). Effects of nicotine in the dopaminergic system of mice lacking the α4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17, 1329-1337.
24. Matsubayashi H, Inoue A, Amano T, Seki T, Nakata Y, Sasa M & Sakai N (2004). Involvement of α7- and α4β2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: A patch clamp and single-cell PCR study using acutely dissociated nigral neurons. Brain Res Mol Brain Res 129, 1-7.
25. Nisell M, Nomikos GG & Svensson TH (1994). Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16, 36-44.
26. Papke RL, Webster JC, Lippiello PM, Bencherif M & Francis MM (2000). The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the α4β2 receptor subtype. J Neurochem 75, 204-216.
27. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K & Changeux JP (1998). Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177.
28. Pidoplichko VI, DeBiasi M, Williams JT & Dani JA (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390, 401-404.
29. Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T & Dani JA (2004). Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learning Memory 11, 60-69.
30. Pontieri FE, Tanda G, Orzi F & Di Chiara G (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255-257.
31. Spanagel R & Weiss F (1999). The dopamine hypothesis of reward: Past and current status. Trends Neurosci 22, 521-527.
32. Sziraki I, Sershen H, Hashim A & Lajtha A (2002). Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res 27, 253-261.
33. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC & Lester HA (2004). Nicotine activation of α4* receptors: Sufficient for reward, tolerance, and sensitization. Science 306, 1029-1032.
34. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J & Swanson LW (1989). Distribution of α 2, α 3, α 4, and β 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. J Comp Neurol 284, 314-335.
35. White FJ (2002). A behavioral/systems approach to the neuroscience of drug addiction. J Neurosci 22, 3303-3305.
36. Wonnacott S, Kaiser S, Mogg A, Soliakov L & Jones IW (2000). Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur J Pharmacol 393, 51-58.
37. Wooltorton JR, Pidoplichko VI, Broide RS & Dani JA (2003). Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23, 3176-3185.
38. Wu J, George AA, Schroeder KM, Xu L, Marxer-Miller S, Lucero L & Lukas RJ (2004). Electrophysiological, pharmacological, and molecular evidence for α7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J Pharmacol Exp Ther 311, 80-91.
39. Zhao L, Kuo YP, George AA, Peng JH, Purandare MS, Schroeder KM, Lukas RJ & Wu J (2003). Functional properties of homomeric, human α7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J Pharmacol Exp Ther 305, 1132-1141.
40. Zoli M, Lena C, Picciotto MR & Changeux JP (1998). Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 18, 4461-4472.